Related Experiment Videos
Breast cancer chemotherapy-related cognitive dysfunction
11Department of Psychiatry and Center for Psycho-Oncology Research, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. tim.a.ahles@dartmouth.edu
Clinical Breast Cancer
|January 21, 2003
Summary
Systemic chemotherapy may cause long-term cognitive changes in breast cancer survivors. Further research is needed to understand mechanisms and develop interventions for chemotherapy-induced cognitive dysfunction.
Area of Science:
- Oncology
- Neuroscience
- Psychology
Background:
- Cognitive side effects of systemic chemotherapy are a growing concern for breast cancer survivors.
- Evidence suggests chemotherapy can induce long-term cognitive changes in a subset of survivors.
- Current understanding of the mechanisms behind these changes is limited.
Purpose of the Study:
- To review evidence linking systemic chemotherapy to cognitive changes.
- To identify limitations in current research and knowledge gaps.
- To discuss potential risk factors and outline future research directions.
Main Methods:
- Literature review of studies on chemotherapy-induced cognitive changes.
- Analysis of existing evidence implicating chemotherapy.
- Discussion of potential moderating factors (age, IQ, psychological, genetic, hormonal).
Main Results:
- Chemotherapy is implicated as a cause of cognitive changes in cancer survivors.
- Significant gaps exist, including a lack of clear mechanistic understanding.
- Factors such as age and genetics may increase susceptibility.
Conclusions:
- Systemic chemotherapy can lead to lasting cognitive impairment in breast cancer survivors.
- Longitudinal studies, mechanistic research (including animal models and imaging), and intervention development are crucial.
- Addressing these cognitive effects is essential for improving survivors' quality of life.